Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Epithelial Neoplasms

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Epithelial Neoplasms in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Research Excerpts

ExcerptRelevanceReference
"However, the cellular origins of CAFs in epithelial ovarian cancers (EOCs) remain poorly understood, and their utility as a source of clinical biomarkers for cancer diagnosis has not been explored in great depth."1.42NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer. ( Gayther, SA; Grun, B; Kan, J; Lawrenson, K; Lee, N; Lin, YG; Mhawech-Fauceglia, P; Millstein, J; Pejovic, T; Swenson, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawrenson, K1
Grun, B1
Lee, N1
Mhawech-Fauceglia, P1
Kan, J1
Swenson, S1
Lin, YG1
Pejovic, T1
Millstein, J1
Gayther, SA1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Epithelial Neoplasms

ArticleYear
NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.
    International journal of cancer, 2015, Mar-15, Volume: 136, Issue:6

    Topics: Animals; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Fibroblasts; Hu

2015